Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Anti GD2 Antibody Therapy - an important approach in the treatment of ...
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti ...
Managing bone and bone marrow involvement in neuroblastoma with anti ...
GD2 antigen expression in human neuroblastoma cell lines and the ...
IgA antibody immunotherapy targeting GD2 is effective in preclinical ...
Anti-GD2 antibodies conjugated to IL15 and IL21 mediate potent anti ...
Human neuroblastoma cell lines vary significantly in GD2 expression and ...
Anti-GD2 immunotherapy of neuroblastoma based on the innate immune ...
GM-CSF, G-CSF, or No Cytokine Therapy with Anti-GD2 Immunotherapy for ...
Transition to a mesenchymal state in neuroblastoma confers resistance ...
Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma
Targets and Antibody Formats for Immunotherapy of Neuroblastoma ...
Monoclonal antibody therapies for high risk neuroblastoma | BTT
Frontiers | Enhancing Neuroblastoma Immunotherapies by Engaging iNKT ...
Comprehensive Review Highlights Importance of Leukine® in Combination ...
Translational immunoPET imaging using a radiolabeled GD2-specific ...
Full article: Monoclonal Antibody Therapies for High Risk Neuroblastoma
Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic ...
Chemotherapeutics Used for High-Risk Neuroblastoma Therapy Improve the ...
CIPO2015: Anti-GD2 mAb and Next Generation mAb-Based Agents, KIR ...
Anti-GD2 antibody primes neuroblastoma cells for removal by the immune ...
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma ...
(PDF) Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic ...
(PDF) Anti-GD2 mAb and Vorinostat synergize in the treatment of ...
Targets for immunotherapy within the neuroblastoma tumour... | Download ...
Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in ...
In vivo imaging of neuroblastomas using GD2-targeting graphene quantum ...
(PDF) Anti-GD2 IgA kills tumors by neutrophils without antibody ...
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for ...
Full article: Anti-GD2 antibody and Vorinostat immunocombination ...
Webinar: Anti-GD2 immunotherapy: A Game Changer in High-Risk ...
(PDF) Anti-GD2 Strategy in the Treatment of Neuroblastoma
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside ...
Anti-GD2 IgA kills tumors by neutrophils without antibody-associated ...
Full article: Effective combination treatment of GD2-expressing ...
Chromosomal instability degrades developmental phenotypes essential for ...
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After ...
Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk ...
Frontiers | Prospects of anti-GD2 immunotherapy for retinoblastoma
(PDF) Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin ...
Anti-GD2 immunotherapy for neuroblastoma: Expert Review of Anticancer ...
Immunotherapy with anti‐GD2 monoclonal antibody in infants with high ...
Internalization of anti-GD2 antibody by human neuroblastoma cell lines ...
Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided ...
Small extracellular vesicles induce resistance to anti-GD2 ...
Human neuroblastoma cell lines differentially internalize anti-GD2 ...
Study of Anti-GD2-800CW for Imaging in Children with Neuroblastoma
(PDF) Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in ...
Full article: Anti-GD2 mAb and Vorinostat synergize in the treatment of ...
Figure 1 from A novel anti-GD2/4-1BB chimeric antigen receptor triggers ...
(PDF) Dual-labeled anti-GD2 targeted probe for intraoperative molecular ...
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated ...
(PDF) Anti-GD2 antibody and Vorinostat immunocombination therapy is ...
(PDF) Correction to: Multidisciplinary Clinical Care in the Management ...
(PDF) Effective combination treatment of GD2-expressing neuroblastoma ...
The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or ...
Anti-gd2 antibody for treatment of neuroblastoma - Eureka | Patsnap
GD2-directed bispecific trifunctional antibody outperforms dinutuximab ...
Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and ...
(PDF) Anti-GD2 antibody-containing immunotherapy postconsolidation ...
Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma ...
(PDF) Unlicensed NK cells target neuroblastoma following anti-GD2 ...
Bispecific Antibodies for the Treatment of Neuroblastoma - PMC
Single-agent activity of the anti-GD2 antibody dinutuximab beta given ...
Prolonged progression-free survival after consolidating second or later ...
Unlicensed NK cells target neuroblastoma following anti-GD2 antibody ...
(PDF) Anti-GD2 antibody-containing immunotherapy post-consolidation ...
(PDF) The Immunocytokine FAP-IL-2v Enhances Anti-Neuroblastoma Efficacy ...
(PDF) Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin ...
Figure 1 from Anti-GD2 Antibody Dinutuximab Beta and Low-Dose ...
(PDF) Multidisciplinary Clinical Care in the Management of Patients ...
Initiation of immunotherapy with activated natural killer cells and ...
Anti-GD2 therapy for relapsed or refractory neuroblastoma | Ruzanna ...
(PDF) Chemotherapeutics Used for High-Risk Neuroblastoma Therapy ...
International Journal of Oncology
Availability of anti-GD2 mAbs for neuroblastoma under clinical trials ...
